Clinical Trials on Pathologic Residual Cancer Cells

Total 30557 results

Zhiyong Yu

Not yet recruiting

Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

Pathologic Residual Cancer Cells

China
University of Leicester

Active, not recruiting

Minimal Residual Disease: A Trial Using Liquid Biopsies in Solid Malignancies. (MARTINI)

Cancer

United Kingdom
M.D. Anderson Cancer Center

Suspended

A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)

Colon Cancer | Resected Stage

United States
Guangdong Provincial People's Hospital

Completed

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Chemotherapy | Non Small Cell Lung Cancer | Immunotherapy | Tumour, Residual

China
Hunan Province Tumor Hospital

Completed

Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment

Non Small Cell Lung Cancer

China
Lumicell, Inc.
National Cancer Institute (NCI)

Completed

Intraoperative Detection of Residual Cancer in Breast Cancer

Breast Cancer

United States
Shanghai Chest Hospital

Recruiting

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Non-small Cell Lung Cancer | Minimal Residual Disease | Immunotherapy | Anti-angiogenesis

China
University Health Network, Toronto
Inivata; The Princess Margaret Cancer Foundation; Ontario Institute for Cancer...

Recruiting

Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection

Non Small Cell Lung Cancer

Canada
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Minimal Residual Disease | NSCLC Stage IV | Nsclc | Metastatic Non Small Cell Lung Cancer

United States
Shandong Cancer Hospital and Institute

Not yet recruiting

Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

HER2-positive Breast Cancer
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Completed

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

Hematopoietic Stem Cell Transplantation | Minimal Residual Disease | Relapse | Donor Lymphocyte Infusion

China
Bristol-Myers Squibb

Withdrawn

An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease (CheckMate 9TN)

Non-Small Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Circulating Tumor DNA
Nanfang Hospital of Southern Medical University

Unknown

HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation

China
Hoffmann-La Roche
NSABP Foundation Inc; German Breast Group

Active, not recruiting

A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)

Breast Cancer

United States, Italy, United Kingdom, Canada, Czechia, Argentina, Austria, Belgium, Brazil, China, France, Germany, Guatemala, Ireland, Panama, Spain, Sweden, Taiwan, Turkey, Colombia, Hong Kong, Peru, Switzerland, South Africa, Israel, G... and more
Gruppo Oncologico del Nord-Ovest

Not yet recruiting

Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease (TRINITY)

Gastric Cancer | HER2-positive Gastric Cancer

Italy
Centre Henri Becquerel

Not yet recruiting

Contribution of Residual Tumour DNA Testing on the Surgical Bed (MARGINS)

Squamous Cell Carcinoma of the Oral Cavity

France
Abramson Cancer Center at Penn Medicine

Recruiting

ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer (ABBY)

Breast Cancer

United States
Karolinska University Hospital
Medical University of Graz; Aarhus University Hospital; Centre Hospitalier Universitaire... and other collaborators

Enrolling by invitation

GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES (GUIDEMRD)

Pancreatic Adenocarcinoma

Sweden
University Hospital, Clermont-Ferrand

Unknown

Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors (TESTIMAR)

Minimal Residual Disease | Fertility Preservation

France
Personalis Inc.

Recruiting

ctDNA Based MRD Testing for NAC Monitoring in TNBC (B-STRONGER-I)

Minimal Residual Disease | TNBC - Triple-Negative Breast Cancer

United States
Dana-Farber Cancer Institute
Genentech, Inc.; Stand Up To Cancer

Active, not recruiting

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

Breast Cancer | Triple Negative Breast Cancer | Circulating Tumor DNA | Residual Cancer

United States
BAIYONG SHEN
GeneCast Biotechnology Co., Ltd.

Not yet recruiting

ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

Pancreatic Cancer Resectable

China
Qilu Hospital of Shandong University
The Affiliated Hospital of Qingdao University; Shandong Provincial Hospital; Jinan... and other collaborators

Recruiting

Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer

Stage II-III Gastric Cancer

China
M.D. Anderson Cancer Center

Recruiting

DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease

Colorectal Cancer | Colon Cancer

United States
University of Ulm
Brainlab AG

Recruiting

Evaluation of 3D Ultrasound in Brain Tumor Surgery (Neuro3DUS)

Residual Tumor

Germany
Institute of Hematology & Blood Diseases Hospital

Recruiting

Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease

Minimal Residual Disease

China
University Hospital, Clermont-Ferrand

Unknown

Contamination of Ovarian Tissue by RT-PCR in Participants With Solid Tumors (OVAMAR)

Minimal Residual Disease | Fertility Preservation

France
Seoul National University Bundang Hospital

Completed

Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery

Neuromuscular Block, Residual

Korea, Republic of
Guangdong Provincial People's Hospital
Shenzhen Chipscreen Biosciences Co.Ltd

Recruiting

A Study of Chidamide With AZA in MRD Positive AML After Transplant

Minimal Residual Disease | AML, Adult

China
Università degli Studi dell'Insubria

Completed

Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer

Residual Tumor | Overall Survival | Disease-free Survival

Italy
Centre Hospitalier Universitaire de Besancon
University Hospital, Rouen; Central Hospital, Nancy, France; University Hospital... and other collaborators

Completed

Validation of a Method to Search Residual Disease in Auto-cryopreserved Ovarian Tissues (VMRDO)

Minimal Residual Disease | Neoplastic Pathology | Cryopreserved Ovarian Tissue

France
Centre Hospitalier Universitaire de Besancon
University Hospital, Rouen; CHU de Reims; Central Hospital, Nancy, France; University... and other collaborators

Completed

Investigating Minimal Residual Disease in Autopreserved Ovarian Tissue in Cases of Neoplastic Pathology (OVAGRAFT)

Neoplastic Pathology | Autopreserved Ovarian Tissue

France
Xianmin Song, MD

Recruiting

Next Generation Sequencing（NGS）Monitors Minimal Residual Disease（MRD）in Allo-PBSCT Patients

NGS Monitor MRD

China
Federal University of Minas Gerais

Completed

Evaluation of Residual Neuromuscular Blockade and of Late Recurarization in the Post Anesthesia Care Unit in Patients Undergoing Videolaparoscopic Cholecystectomy

Neuromuscular Block, Residual

Brazil
Azienda Ospedaliera di Padova

Completed

Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia

Postoperative Residual Curarization | Residual Neuromuscular Block

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Not yet recruiting

Incidence of Postoperative Residual Curarization (PORC)

Neuromuscular Blockade, Residual

Italy
Zhejiang University

Completed

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

Measurable Residual Disease

China
University Medical Center Ho Chi Minh City (UMC)

Recruiting

Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description

Gastric Cancer | ctDNA

Vietnam
Institute of Hematology & Blood Diseases Hospital

Not yet recruiting

A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive

Minimal Residual Disease | Bone Marrow Transplant | Ph+ ALL

China
NorthShore University HealthSystem

Terminated

Electromyographic Monitoring and Postoperative Recovery

Postoperative Residual Neuromuscular Blockade

United States
Exact Sciences Corporation
Labcorp Corporation of America Holdings, Inc

Recruiting

First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer (MRD)

Colorectal Cancer

United Kingdom, Spain, Italy, Israel
Enterome

Completed

EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer (CLAUDE)

Colorectal Cancer

United States
WeiWei Xiao
Haplox Biotechnology Co., Ltd.

Recruiting

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

Minimal Residual Disease | Circulating Tumor DNA | Rectal Adenocarcinoma | Neoadjuvant Chemoradiotherapy

China
University of Aarhus
Aarhus University Hospital

Recruiting

DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies (DANISH_MRD)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage I

Denmark
University Hospital, Montpellier

Not yet recruiting

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

Colorectal Cancer | Minimal Residual Disease | Liquid Biopsy | Stage III Colon Cancer
Peking University People's Hospital

Unknown

Interferon α for the Therapy of Minimal Residual Disease

Leukemia

China
RenJi Hospital
Peking University First Hospital; Xiangya Hospital of Central South University and other collaborators

Recruiting

Circulating Tumour DNA and Urine Tumor DNA Detection of Minimal Residual Disease in Locally Advanced Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy: A Cohort Study

Muscle Invasive Upper Tract Urothelial Carcinoma

China
M.D. Anderson Cancer Center
Bellicum Pharmaceuticals, Inc.

Not yet recruiting

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

Colorectal Cancer | Minimal Residual Disease

United States
Exact Sciences Corporation
NSABP Foundation Inc

Recruiting

CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer (MRD)

Colorectal Cancer

United States
Tampere University Hospital

Active, not recruiting

Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases

Colorectal Cancer | Residual Disease

Finland

Clinical Trials on Pathologic Residual Cancer Cells

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations